Masimo (NASDAQ:MASI) Hits New 12-Month High – Time to Buy?

Masimo Corporation (NASDAQ:MASI)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $180.02 and last traded at $178.6250, with a volume of 2581 shares changing hands. The stock had previously closed at $178.55.

Analysts Set New Price Targets

Several brokerages recently issued reports on MASI. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research note on Tuesday, February 17th. Weiss Ratings raised shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Piper Sandler downgraded shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective for the company. in a research report on Tuesday, February 17th. Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Finally, Wells Fargo & Company raised Masimo to a “hold” rating in a research report on Wednesday, March 18th. Nine research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Masimo currently has a consensus rating of “Hold” and a consensus price target of $180.40.

Masimo Stock Down 0.0%

The firm has a 50-day moving average price of $177.60 and a 200 day moving average price of $155.29. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45. The company has a market cap of $9.35 billion, a price-to-earnings ratio of -16.93, a P/E/G ratio of 1.81 and a beta of 1.13.

Hedge Funds Weigh In On Masimo

Several institutional investors and hedge funds have recently made changes to their positions in MASI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock worth $1,894,000 after acquiring an additional 66 shares in the last quarter. 180 Wealth Advisors LLC increased its stake in shares of Masimo by 2.5% in the 1st quarter. 180 Wealth Advisors LLC now owns 2,728 shares of the medical equipment provider’s stock worth $485,000 after acquiring an additional 66 shares in the last quarter. Clearstead Advisors LLC increased its stake in shares of Masimo by 18.4% in the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $69,000 after acquiring an additional 73 shares in the last quarter. Hantz Financial Services Inc. increased its stake in shares of Masimo by 12.9% in the 4th quarter. Hantz Financial Services Inc. now owns 655 shares of the medical equipment provider’s stock worth $85,000 after acquiring an additional 75 shares in the last quarter. Finally, Assetmark Inc. increased its stake in shares of Masimo by 5.5% in the 4th quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider’s stock worth $241,000 after acquiring an additional 97 shares in the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.